Biomutant Developers Assures Fans That A Release Is Still On The Way

  • Playstation 4
  • Windows
  • Xbox One
  • Action
Biomutant
Biomutant DUALSHOCKERS

Developers of the upcoming open-world game Biomutant recently assured fans via a Twitter post that the game is not canceled and is still on the way. Biomutant was supposed to launch in 2018, but was delayed as developers needed more time to finish the project. In November of last year, developer Experiment 101 announced that the game is in “the final stages of polishing”. However, they still don’t have a release window. Devs said that they will announce the launch date when they are sure that they can meet it.

Here’s the full statement by Biomutant developers, Experiment 101:

“We know that many of you are wondering if the game is still in development. Let us assure you that we’ve never been working harder and more focused on it than now! We are doing everything we can to make this the best game all of us have ever worked on and that it will be as entertaining and great as we can possibly make it. We can only hope for your continued support and patience as we complete the final stages of its development. As some of you might understand or know, the work involved in finishing a game is long, challenging and unpredictable. The sheer magnitude, size, and length of Biomutant adds to said effort. We will reveal the release date as soon as everyone at our studio feels confident about hitting that date and that the game is ready for it.”

Biomutant was initially announced back in 2017. The game lets you play as a customizable character “with powerful mutations, bionic prosthetics, and weapons”. You can also genetically modify your character with claws, barbed tails, and other sorts of additions. As mentioned above, we don’t have a release window, however, it is confirmed that it will release on PlayStation 4, Xbox One, and PC.

So what do you think? Are you excited about Biomutant? Or have you lost interest due to delays? Let us know your thoughts in the comments section below.

Join the Discussion
Top Stories